Yuyu Pharma launches three 'Kozal' products to relieve nasal congestion and rhinitis, targeting the nasal care market
Predicted impact: Low
Three nasal care product launches; small new product line with no size given.
Yuyu Pharma유유제약
000220 · KOSPI · ₩000220 · 유유제약
₩3,670▲ ₩30 (0.82%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −11.99%
- Market cap
- ₩58B
- Enterprise value
- ₩42B
- P/E
- 4.6×
- P/B
- 0.4×
- Dividend yield
- 3.1%
- ROE
- 9.3%
- Net margin
- 8.7%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−28.0% from the high
₩3,320Today: ₩3,645 – ₩3,690₩5,100
Returns
- 1W−1.9%
- 1M−0.7%
- 3M+3.7%
- 6M−15.0%
- YTD−18.7%
- 1Y−12.0%
- Volume today
- 20,242
- 0.4× the 20-day average
- Traded today
- ₩74M
- Listed shares
- 15,747,462
- EPS (12 months)
- ₩794
- Earnings yield 21.6%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 30 of 100 (50 is a normal day for this stock).
- MomentumFlat-1.7% over the last month; the price is below its 20-day average.
- News impactLow4 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Yuyu Pharma stock overview
Yuyu Pharma (유유제약, KRX: 000220) is listed on KOSPI, in the Biotech & Pharma sector. Yuyu Pharma is a Korean company founded in 1941 that manufactures and sells pharmaceuticals and health functional foods, operating a production plant in Jecheon, Chungcheongbuk-do. Its shares closed at ₩3,670 on Oct 27, 2026, up 0.82% on the day, giving it a market value of ₩58B.
Key facts
- Market cap
- ₩58B
- Sector
- Biotech & Pharma
- Latest price change
- +0.82%
- As of
- Oct 27, 2026
- Main business
- Yuyu Pharma is a Korean company founded in 1941 that manufactures and sells pharmaceuticals and health functional foods, operating a production plant in Jecheon, Chungcheongbuk-do.
Quick answers about Yuyu Pharma
- What does Yuyu Pharma do?
- Yuyu Pharma is a Korean company founded in 1941 that manufactures and sells pharmaceuticals and health functional foods, operating a production plant in Jecheon, Chungcheongbuk-do. It supplies prescription medicines to domestic hospitals and clinics, manufactures medicines on contract for other Korean pharmaceutical companies, and exports finished drugs to countries including Southeast Asia and South America. Its consolidated subsidiaries include Yuyu Healthcare, which makes health functional foods on an OEM/ODM basis, and Yuyu Medical, which sells and wholesales medical devices.
- What is the market cap of Yuyu Pharma?
- The market capitalisation of Yuyu Pharma was ₩58B at the close on Oct 27, 2026.
- Who are the largest shareholders of Yuyu Pharma?
- According to the latest official filings, the largest reported holders are Yoo Won-sang (35.95%, as of Jul 21, 2026); Rhinos Asset Management (3.74%, as of May 29, 2025); National Pension Service (0.12%, as of Dec 31, 2025).
- When is the next earnings report from Yuyu Pharma?
- Korean companies rarely announce results dates in advance. Based on when Yuyu Pharma filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Yuyu Pharma?
- Yes. The National Pension Service held 0.12% of Yuyu Pharma shares as of Dec 31, 2025.
Company profile
Yuyu Pharma is a Korean company founded in 1941 that manufactures and sells pharmaceuticals and health functional foods, operating a production plant in Jecheon, Chungcheongbuk-do. It supplies prescription medicines to domestic hospitals and clinics, manufactures medicines on contract for other Korean pharmaceutical companies, and exports finished drugs to countries including Southeast Asia and South America. Its consolidated subsidiaries include Yuyu Healthcare, which makes health functional foods on an OEM/ODM basis, and Yuyu Medical, which sells and wholesales medical devices.
Written by AI from the company's latest annual report.
- Korean name
- 유유제약
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 유원상, 박노용(각자대표)
- Founded
- Feb 1941
- Listed
- Nov 1975
- Listed shares
- 15,747,462
- Fiscal year ends
- Month 12
- Website
- www.yuyu.co.kr
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent news
Yoo Yu Pharmaceutical Develops 'Unicap', a Combination Formulation Platform Technology
Predicted impact: Low
Formulation platform tech already reported in the last 14 days; no financial impact stated.
Yuyu Pharma puts tablets and soft capsules in one pill, develops multi-dosage-form technology
Predicted impact: Low
Multi-dosage tablet and capsule technology development; small pipeline news for a small pharma.
Recent filings
See all- Adjustment of Conversion Price, Warrant Exercise Price and Exchange Price (Informational Disclosure)Sep 22, 2026
- Half-year report (Jun 2026)Aug 13, 2026
- Amended: Acquisition of property, plant and equipmentJul 31, 2026
- 5%+ holding reportJul 21, 2026
- 5%+ holding reportJul 1, 2026
Titles in Korean until English translations are added.
Also known as: Yuyu Pharma / 유유제약 / 000220 / KRX:000220
Source: KRX statistical information